Brigit Biofarmaka Teknologi Tbk. vs Multi Makmur Lemindo Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Multi Makmur Lemindo Tbk. trades at Rp124 (market cap 424.84B, 39.61M 24h volume). The key difference: Multi Makmur Lemindo Tbk. is far larger — about 2.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Multi Makmur Lemindo Tbk. is more actively traded (39.61M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | PIPA | |
|---|---|---|
Market Cap | 172.82B | 424.84B |
Volume | 592.2K | 39.61M |
Lot | 5.92K | 396.07K |
Turnover | 147.05M | 4.89B |
Average Price | 248.31 | 123.59 |
Value | 147.05M | 4.89B |
Indicative Equilibrium Price | 254 | 124 |
Indicative Equilibrium Volume | 10 | 2.9K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Multi Makmur Lemindo Tbk (the Company) was established based on Notarial Deed No. 66 dated January 11, 2012 of Deni Nugraha, S.E., S.H., M.Kn., notary in Tangerang. The Company started its commercial operations in 2005.
Read more on PIPA →